Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.
about
Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in TanzaniaExpression of mRNA transcripts encoding membrane transporters detected with whole transcriptome sequencing of human brain and liverSLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic groupFrequencies of two functionally significant SNPs and their haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in six ethnic groups of Pakistani population.Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populationsGenome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans.Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins.Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings.The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.Pharmacokinetics of rosuvastatin in 30 healthy Zimbabwean individuals of African ancestry.Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1.A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines.Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype
P2860
Q28481272-93605222-FA0F-4527-9633-B57E458940A2Q34042444-04652A19-F28D-4EBF-99EA-56DA13BFAA95Q34047278-78E319F6-EF29-421A-877A-278FD9F49C6DQ34065757-9D62092B-853E-42B9-B78F-8D81D4F225A9Q34826590-264D71BB-2FE0-4D61-8682-D42F509E42EDQ36145491-228424E8-6ED6-441D-8769-83CDD04AABDDQ36623470-E4DD1A8C-1455-4A2E-8977-80533B04DABCQ37492042-23D4E02A-D144-4105-9A1F-FD6F7947AA66Q37715233-7DFB59A8-07D7-4A2B-8647-E72EE5119DA4Q38222511-DCAD4EF6-3036-44D5-A431-B0C5B49465A6Q39182431-468E66E7-7B41-4B41-8CFB-B293C7C10064Q40186032-8421268C-DDDC-4018-A04D-B9A69CE768DCQ42562160-45A735AC-C8D3-4A92-9915-5F6063471DDBQ42710782-E63C98D7-5912-4934-91D4-912723E19F25Q45950387-6DCF5412-E476-4C80-9953-08336683A1EEQ58612379-54D9905F-93CE-4272-895E-31FB981F0E82
P2860
Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@en
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@nl
type
label
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@en
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@nl
prefLabel
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@en
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@nl
P2093
P2860
P50
P1476
Frequency of the SLCO1B1 388A> ...... new LightCycler®-based method.
@en
P2093
Eliford Ngaimisi
Johanna Weiss
Michael Marcus Hoffmann
Sabina Mugusi
Sonja König
P2860
P2888
P304
P356
10.1007/S00228-011-1065-9
P577
2011-06-01T00:00:00Z